Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-19 Purchase | 2022-05-23 4:54 pm | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 3,948 | $0.644 | $2,543 | 48,091 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-01 Option Award | 2023-03-03 5:00 pm | N/A 2023-03-01 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer | 90,000 | $0 | 138,091 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-21 4:05 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 62,500 | $0 | 106,643 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 8:22 pm | N/A 2029-03-07 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer | 62,500 | $0 | 106,643 (Direct) | View |
| 2020-12-28 Conversion | 2020-12-29 9:52 pm | 2020-12-28 2021-12-31 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 441,432 | $0 | 144,143 (Indirect) | View |
| 2020-12-22 Option Award | 2020-12-29 9:52 pm | N/A 2030-12-22 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 100,000 | $0 | 144,143 (Direct) | View |
| 2020-12-28 Conversion | 2020-12-29 9:52 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 44,143 | $10 | 144,143 (Indirect) | View |
Ownership | 2020-12-22 8:42 pm | 2020-08-25 2027-08-25 | Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer | 0 | $0 | 171,854 (Indirect) | View |